Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital)

Description

List of Tables

Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital)-Global Forecast to 2031

The global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the protein assays market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the protein assays market is driven by increasing pharmaceutical R&D expenditure, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth.

Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are a major challenge for the market's growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).

Among all the offerings studied in this report, in 2024, the reagents & kits segment is expected to account for the largest share of the protein assays market. The wide availability of consumables, recurring use of protein assay kits, and increasing adoption of these kits by researchers to estimate protein concentration in unknown samples are contributing to the largest share of the segment.

Among all the types studied in this report, in 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. Dye-based assays have exceptional speed and simplicity, making them suitable for high throughput screening and allowing researchers to process a large number of samples. Such factors support the large market share of this segment.

Among all the technologies studied in this report, in 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. Absorbance assays are applied to a wide variety of samples, making them ideal for research applications. Additionally, the reagents used in the assays do not cross-react with each other, increasing the reliability of the method. This is boosting the adoption of absorbance assays, thereby leading to segment growth.

Among all the applications studied in this report, in 2024, the drug discovery segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the increased use of protein assay in life science research, increased spending on pharmaceutical R&D, the need to develop new therapies owing to increasing disease prevalence, and high investments in drug discovery & development.

Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology research segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the growing number of research and clinical laboratories, increased investments in R&D, and rising funding for pharmaceutical research. The funding for research laboratories is increasing due to the rising demand for new drugs and therapies, which is driving the demand for protein assays.

An in-depth analysis of the geographical scenario of the global protein assays market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region.

In 2024, North America is expected to account for the largest share of the protein assays market. This regional market's large share is attributed to several factors, including favorable government initiatives supporting research and development, substantial R&D investments by pharmaceutical and biotechnology companies in drug and biomarker development, increased healthcare expenditures, the growing prevalence of chronic diseases, and the presence of key market players in the region.

Scope of the Report:

Protein Assays Market Assessment-by Offering

Reagents & Kits
Instruments & Accessories

Protein Assays Market Assessment-by Type

Dye-based Assay
Copper-based Assay
Other Assay Types

Note: Other assay types consist of test strip-based and fluorescent protein assays.

Protein Assays Market Assessment-by Technology

Fluorescence-based Protein Assay
Absorbance-based Protein Assay
Colorimetric-based Protein Assay

Protein Assays Market Assessment-by Application

Drug Discovery
Research & Development
Clinical Diagnosis
Label Claims
Other Applications

Note: Other applications include raw material inspection and forensic proteomics

Protein Assays Market Assessment-by End User

Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Laboratories
Food & Beverage Companies
Other End Users

Note: Other end users consist of academic institutes & research centers, forensic labs, and agriculture companies

Protein Assays Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa

Product Code: MRHC - 1041120

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Process of Data Collection and Validation
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

4.1. Overview
4.2. Drivers
- 4.2.1. Increasing Pharmaceutical R&D Expenditure
- 4.2.2. Increasing Use of Protein Assay in Drug Discovery & Development
- 4.2.3. Growth in Food & Beverage Industry
- 4.2.4. Rising Use of Protein Assays in Clinical Diagnostic Tests
4.3. Restraint
- 4.3.1. High Cost of Protein Quantification Devices
4.4. Opportunities
- 4.4.1. Increasing Focus on Proteomics Research
- 4.4.2 Use of Protein Assays in Personalized Medicines
4.5. Challenges
- 4.5.1. High Chances of Error With Complex Samples
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Porter's 5 Force Analysis

5. Protein Assays Market Assessment-by Offering

5.1. Overview
5.2. Reagents & Kits
5.3. Instruments & Accessories

6. Protein Assays Market Assessment-by Type

6.1. Overview
6.2. Dye-based Assay
6.3. Copper-based Assay
6.4. Other Assay Types

7. Protein Assays Market Assessment-by Technology

7.1. Overview
7.2. Fluorescence-based Protein Assays
7.3. Absorbance-based Protein Assays
7.4. Colorimetric-based Protein Assays

8. Protein Assays Market Assessment-by Application

8.1. Overview
8.2. Drug Discovery
8.3. Research & Development
8.4. Clinical Diagnosis
8.5. Label Claims
8.6. Other Applications

9. Protein Assays Market Assessment-by End User

9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Hospitals & Diagnostic Laboratories
9.4. Food & Beverage Companies
9.5. Other End Users

10. Protein Assays Market Assessment-by Geography

10.1. Overview
10.2. North America
- 10.2.1. U.S.
- 10.2.2. Canada
10.3. Europe
- 10.3.1. Germany
- 10.3.2. France
- 10.3.3. U.K.
- 10.3.4. Italy
- 10.3.5. Spain
- 10.3.6. Rest of Europe (RoE)
10.4. Asia-Pacific
- 10.4.1. China
- 10.4.2. Japan
- 10.4.3. India
- 10.4.4. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
- 10.5.1. Brazil
- 10.5.2. Mexico
- 10.5.3. Rest of Latin America (RoLATAM)
10.6. Middle East and Africa

11. Competition Analysis

11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
- 11.4.1. Industry Leaders
- 11.4.2. Market Differentiators
- 11.4.3. Vanguards
- 11.4.4. Emerging Companies
11.5. Market Share Analysis/Market Ranking, by Key Players (2023)

12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)

12.1. Bio-Rad Laboratories, Inc.
12.2. Thermo Fisher Scientific Inc.
12.3. Revvity, Inc.
12.4. Merck KGaA
12.5. Abcam plc
12.6. F. Hoffmann-La Roche AG
12.7. Danaher Corporation
12.8. Promega Corporation
12.9. Cell Signaling Technology, Inc.
12.10. Agilent Technologies, Inc.
12.11. Novus Biologicals

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

13. Appendix

13.1. Available Customization
13.2. Related Reports